Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001447028-26-000027
Filing Date
2026-06-05
Accepted
2026-06-05 16:05:30
Documents
16
Effectiveness Date
2026-06-05
Reference 429
333-273647

Document Format Files

Seq Description Document Type Size
1 S-8 a2026s-8form.htm S-8 100051
2 exfilingfees.htm   iXBRL EX-FILING FEES 16349
3 EX-5.1 a2026s-8farrisconsentex51.htm EX-5.1 9369
4 EX-23.1 a2026s-8eyconsentex231.htm EX-23.1 2307
5 farrisfootera.jpg GRAPHIC 5687
6 image1a.jpg GRAPHIC 1992
7 imagea.jpg GRAPHIC 4310
  Complete submission text file 0001447028-26-000027.txt   265581

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 5063
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-296539 | Film No.: 261069052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)